BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 6302168)

  • 21. Surveillance in stage I nonseminomatous germ cell tumours of the testis.
    Zuniga A; Kakiashvili D; Jewett MA
    BJU Int; 2009 Nov; 104(9 Pt B):1351-6. PubMed ID: 19840012
    [No Abstract]   [Full Text] [Related]  

  • 22. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk-guided after-care of testicular tumor].
    Schölermann KH; Dettmann R; Hartmann M
    Urologe A; 1996 Jul; 35(4):326-30. PubMed ID: 8928363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
    Sparwasser C; Treiber U; Beckert R; Pust RA
    Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of retroperitoneal lymphadenectomy in mature teratoma of the testis.
    Heidenreich A; Moul JW; McLeod DG; Mostofi FK; Engelmann UH
    J Urol; 1997 Jan; 157(1):160-3. PubMed ID: 8976241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late relapse of nonseminomatous germ cell tumours.
    Oldenburg J; Fosså SD
    BJU Int; 2009 Nov; 104(9 Pt B):1413-7. PubMed ID: 19840022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated solitary bony metastasis of a nonseminomatous germ cell tumor.
    Aldejmah A; Soulières D; Saad F
    Can J Urol; 2007 Feb; 14(1):3458-60. PubMed ID: 17324327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
    Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
    J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-seminomatous germ cell testis tumors--how do you manage clinical state IIA?
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():571-4. PubMed ID: 3008185
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
    Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
    J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late relapse of testicular cancer 21 years after first complete remission: a case report.
    Kohei N; Kinoshita H; Kamoto T; Terai A; Kakehi Y; Ogawa O
    Hinyokika Kiyo; 2008 Jan; 54(1):39-42. PubMed ID: 18260359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.